Kuros Biosciences AG (FRA:YTSN)
Germany flag Germany · Delayed Price · Currency is EUR
27.22
0.00 (0.00%)
At close: Jan 30, 2026

Kuros Biosciences AG Cash Flow Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-6.07-4.29-13.73-14.6-7.54-11.52
Depreciation & Amortization
2.612.612.72.752.812.63
Other Amortization
0.020.020.050.090.070.04
Asset Writedown & Restructuring Costs
5.15.14.543.6--
Stock-Based Compensation
5.135.130.921.030.390.75
Other Operating Activities
2.93-1.563.91.05-0.99-0.41
Change in Accounts Receivable
-13.5-7.89-4.57-1.64-0.74-0.38
Change in Inventory
-5.14-4.65-2.48-1.59-0.34-0.52
Change in Accounts Payable
2.815.560.060.49--
Change in Other Net Operating Assets
7.13.673.351.470.880.16
Operating Cash Flow
0.823.14-8.84-7.35-5.46-9.24
Capital Expenditures
-1.49-1.1-0.32-0.39-0.3-0.06
Sale (Purchase) of Intangibles
0-0.02-0.01-0.01-0.07-0.16
Investing Cash Flow
-1.49-1.11-0.33-0.4-0.37-0.22
Short-Term Debt Issued
----6.40.1
Total Debt Issued
----6.40.1
Short-Term Debt Repaid
----2.37--
Long-Term Debt Repaid
--0.6-0.67-0.34-0.32-0.27
Total Debt Repaid
-0.65-0.6-0.67-2.72-0.32-0.27
Net Debt Issued (Repaid)
-0.65-0.6-0.67-2.726.08-0.17
Issuance of Common Stock
2.231.940.56-18.62
Other Financing Activities
----0.06--1.37
Financing Cash Flow
1.581.34-0.173.226.0817.08
Foreign Exchange Rate Adjustments
2.570.45-0.52-0.03-0.01-0.03
Net Cash Flow
3.483.81-9.86-4.560.247.59
Free Cash Flow
-0.672.05-9.16-7.74-5.76-9.3
Free Cash Flow Margin
-0.65%2.71%-27.29%-43.05%-41.72%-230.25%
Free Cash Flow Per Share
-0.010.06-0.25-0.23-0.18-0.38
Cash Interest Paid
0.070.020.060.080.120.08
Cash Income Tax Paid
1.370.870.5500.050
Levered Free Cash Flow
-3.834.01-8.55-4.485.24-7.6
Unlevered Free Cash Flow
-0.484.11-8.43-4.486.1-7.07
Change in Working Capital
-8.73-3.31-3.65-1.27-0.19-0.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.